Israel Steiner. Show Affiliations »
Abstract
Entities: Chemical Disease Gene Species
Mesh： See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedDisease ProgressionEarly DiagnosisEurope/epidemiologyHumansImmunologic Factors/therapeutic useIncidenceLeukoencephalopathy, Progressive Multifocal/diagnosisLeukoencephalopathy, Progressive Multifocal/epidemiologyMultiple Sclerosis/diagnosisMultiple Sclerosis/drug therapyMultiple Sclerosis/epidemiologyNatalizumabReview Literature as TopicUnited States/epidemiology
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedImmunologic FactorsNatalizumab
Year: 2010 PMID： 20494319 DOI： 10.1016/S1474-4422(10)70122-8
Source DB: PubMed Journal: Lancet Neurol ISSN： 1474-4422 Impact factor: 44.182